Gravar-mail: NIMG-28 TREATMENT RESPONSE EVALUATION USING FET PET COMPARED TO STANDARD MRI IN GLIOBLASTOMA PATIENTS AT FIRST RECURRENCE TREATED WITH BEVACIZUMAB PLUS LOMUSTINE